Biotech Firm Trials Ozempic-Inspired Treatment for Overweight Cats | Firstpost America | N18G

Ozempic, the blockbuster drug that transformed human weight loss, is now being tested for cats. A San Francisco–based biotech company has launched a clinical trial, dubbed MEOW ONE, to treat overweight felines using an Ozempic-style medication. Instead of injections, cats receive a tiny implant placed under the skin, slowly releasing the drug over several months. The treatment mimics hormones that regulate appetite and blood sugar, aiming to reduce fat and improve metabolic health without disrupting feeding routines. The trial will monitor overweight cats for 12 weeks. With more than half of pet cats globally estimated to be overweight, and obesity-linked diseases on the rise, researchers hope the experimental treatment could one day reshape feline healthcare. 

---

Ozempic | Ozempic Trial Cats | Weight Loss Drugs | Firstpost America | Eric Ham | War | Geopolitics | Global Economy | Firstpost | World News | Latest News | Global News | International News | Trending News

#ozempiccattrials #ozempic #weightlossdrugs #firstpostamerica #ericham #war #geopolitics #economy #firstpost #worldnews #latestnews #globalnews #internationalnews #trendingnews

Firstpost is an Indian news and media website. Get all the incisive opinions, in-depth analyses and other visual stories that matter to you and the world right here on this channel.

Subscribe to Firstpost channel and press the bell icon to get notified when we go live. https://www.youtube.com/@Firstpost

Follow Firstpost on Website:
https://www.firstpost.com

Follow Firstpost on Instagram:
https://www.instagram.com/firstpost/

Follow Firstpost on Facebook:
https://www.facebook.com/firstpostin/

Follow Firstpost on Twitter:
https://twitter.com/firstpost

Follow Firstpost on WhatsApp: https://www.whatsapp.com/channel/0029Va6zOIrEQIamseyg762V Receive SMS online on sms24.me

TubeReader video aggregator is a website that collects and organizes online videos from the YouTube source. Video aggregation is done for different purposes, and TubeReader take different approaches to achieve their purpose.

Our try to collect videos of high quality or interest for visitors to view; the collection may be made by editors or may be based on community votes.

Another method is to base the collection on those videos most viewed, either at the aggregator site or at various popular video hosting sites.

TubeReader site exists to allow users to collect their own sets of videos, for personal use as well as for browsing and viewing by others; TubeReader can develop online communities around video sharing.

Our site allow users to create a personalized video playlist, for personal use as well as for browsing and viewing by others.

@YouTubeReaderBot allows you to subscribe to Youtube channels.

By using @YouTubeReaderBot Bot you agree with YouTube Terms of Service.

Use the @YouTubeReaderBot telegram bot to be the first to be notified when new videos are released on your favorite channels.

Look for new videos or channels and share them with your friends.

You can start using our bot from this video, subscribe now to Biotech Firm Trials Ozempic-Inspired Treatment for Overweight Cats | Firstpost America | N18G

What is YouTube?

YouTube is a free video sharing website that makes it easy to watch online videos. You can even create and upload your own videos to share with others. Originally created in 2005, YouTube is now one of the most popular sites on the Web, with visitors watching around 6 billion hours of video every month.